Monday, June 05, 2006

Xeloda (capecitabine) plus paclitaxel is as effective as and safer than epirubicin plus paclitaxel plus paclitaxel plus paclitaxel

A new randomised phase III study in advanced breast cancer shows the combination of Xeloda (capecitabine) plus paclitaxel is equally as effective and safer than the, recognised as highly potent, combination of epirubicin (an anthracycline) plus paclitaxel.(1) It is well known that anthracyclines (epirubicin and others) are associated with cumulative cardiac toxicity, which can be life-threatening, restricting the number of treatments a patient can receive during her lifetime due to progressive heart failure. Importantly, Xeloda plus paclitaxel (known as 'XP') is safer for patients as it has no cumulative side-effects. --Click the title of this post to read the full article from its source--


Post a Comment

<< Home

/* WebRing Code */